These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24809434)

  • 1. Pre-analytical heat treatment and a FVIII ELISA improve Factor VIII antibody detection in acquired haemophilia A.
    Batty P; Platton S; Bowles L; Pasi KJ; Hart DP
    Br J Haematol; 2014 Sep; 166(6):953-6. PubMed ID: 24809434
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.
    Batty P; Moore GW; Platton S; Maloney JC; Palmer B; Bowles L; Pasi KJ; Rangarajan S; Hart DP
    Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay.
    Sahud MA; Pratt KP; Zhukov O; Qu K; Thompson AR
    Haemophilia; 2007 May; 13(3):317-22. PubMed ID: 17498082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
    Qadura M; Waters B; Burnett E; Chegeni R; Hough C; Othman M; Lillicrap D
    Haemophilia; 2011 Mar; 17(2):288-95. PubMed ID: 21091850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acquired haemophilia due to autoantibodies against factor VIII].
    von Depka Prondzinski M
    Hamostaseologie; 2003 Feb; 23(1):28-35. PubMed ID: 12567197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired haemophilia].
    Buczma A; Windyga J
    Pol Arch Med Wewn; 2007; 117(5-6):241-5. PubMed ID: 18030874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired haemophilia A: a 2013 update.
    Franchini M; Mannucci PM
    Thromb Haemost; 2013 Dec; 110(6):1114-20. PubMed ID: 24008306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.
    Boylan B; Miller CH
    Haemophilia; 2018 May; 24(3):487-491. PubMed ID: 29461004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.
    Klintman J; Hillarp A; Donfield S; Berntorp E; Astermark J
    Haemophilia; 2013 Jan; 19(1):106-12. PubMed ID: 22762454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of F.VIII:C antibodies by an enzyme-linked immunosorbent assay.
    Mondorf W; Ehrenforth S; Vigh Z; Last J; Tippmann G; Kreuz W; Scharrer I
    Vox Sang; 1994; 66(1):8-13. PubMed ID: 8146988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a novel ELISA screening test for detection of factor VIII inhibitory antibodies in haemophiliacs.
    Martin PG; Sukhu K; Chambers E; Giangrande PL
    Clin Lab Haematol; 1999 Apr; 21(2):125-8. PubMed ID: 10342072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case history of acquired haemophilia A].
    Cermáková Z; Hrdličková R; Blahutová S; Ligová A
    Vnitr Lek; 2013 Apr; 59(4):313-6. PubMed ID: 23711058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flow cytometry evaluation of anti-FVIII antibodies: correlation with ELISA and Bethesda assay.
    Irigoyen MB; Primiani L; Felippo M; Candela M; Bianco RP; De Bracco MM; Galassi N
    Haemophilia; 2011 Mar; 17(2):267-74. PubMed ID: 21070488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
    Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes?
    Hausammann S; Vogel M; Kremer Hovinga JA; Lacroix-Desmazes S; Stadler BM; Horn MP
    PLoS One; 2013; 8(4):e60688. PubMed ID: 23626669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up.
    Chansavang A; Philippe A; Bozinovic I; Ben Hadj Ali K; Smadja D; Helley D; Darnige L; Mauge L
    Ann Hematol; 2022 Nov; 101(11):2453-2460. PubMed ID: 36125542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.
    Franchini M; Girelli D; Olivieri O; Bozzini C; Guiotto M; Zardini G; Lippi G; Manzato F; Gandin G
    Haematologica; 2005 Mar; 90(3):ECR16. PubMed ID: 15753057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A.
    Lindgren A; Wadenvik H; Tengborn L
    Haemophilia; 2002 Sep; 8(5):644-8. PubMed ID: 12199673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nonneutralizing antibodies against factor VIII in severe haemophilia A patients from India.
    David S; Mathews NS; Singh GS; Korula A; Aboobacker FN; Abraham A; George B; Srivastava A; Mathews V; Nair SC
    Blood Coagul Fibrinolysis; 2019 Oct; 30(7):337-340. PubMed ID: 31449137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.